Impact of Safety Concerns and Regulatory Changes on the Usage of Erythropoiesis-Stimulating Agents and RBC Transfusions
Abstract
The impact of regulatory restrictions of erythropoiesis-stimulating agents (ESAs) on their use and on RBC transfusions was examined. A multivariate logistic regression showed a significant decline in ESA use without an increase in RBC transfusions